The Yieldstreet team was proud to participate in the Walk MS annual fundraising event in Jersey City, NJ April 30. It’s one of several during spring and summer that help raise funds for The National Multiple Sclerosis Society. This year’s goal is $24 million, and more than $22 million has already been raised.
“I couldn’t be happier or more excited about Yieldstreet sponsoring an event that has been so near and dear to my heart for well over a decade,” said Joel Greengrass Chief People Officer at Yieldstreet.
Walk MS hits home for Joel. He was diagnosed with MS just over 16 years ago. His “Team Greengrass” has participated in more than a dozen Walk MS and other MS fundraising events, and they have helped raise more than $300,000 for the National MS society.
“This event is one of the many ways that we give back to those who are less fortunate than me,” he said.
Walk MS is the 7th largest nonprofit fundraising event in the United States, with more than 230 events across the country. 10 Walk MS events in New Jersey raised $986,000 at the beginning of May, intending to raise $1 million by the end of September.
The National Multiple Sclerosis Society says, “Walk MS brings together passionate people for a powerful purpose: to end MS forever.”
According to the National MS website, multiple sclerosis is a disease that impacts a person’s brain and spinal cord. The exact cause of MS is unknown, but it causes the immune system to attack the brain and spinal cord, disrupting nervous system signals. It can result in several unpredictable symptoms such as numbness, tingling, mood changes, memory problems, pain, fatigue, blindness, and paralysis.
Joel and “Team Greengrass” joined 600 people in Jersey City’s Liberty State Park for Walk MS at the end of April. 85% of the people who participate in Walk MS are on teams like Joel’s, made up of family, friends, and corporate colleagues. A 2019 landmark study found nearly one million people live with MS in the United States. It was the first scientifically sound study since 1975 about the prevalence of MS.
Congress approved funding in 2018 for a national neurological disease surveillance system to provide deeper information about the prevalence of MS. As that data is collected and used to learn more about the disease, the National MS Society and people like Joel will do their part to help others living with MS.
“I am consistently amazed and humbled by everyone’s generosity and support in helping to not only find a cure but also help those suffering from MS every day,” Joel said.
Yieldstreet provides access to alternative investments previously reserved only for institutions and the ultra-wealthy. Our mission is to help millions of people generate $3 billion of income outside the traditional public markets by 2025. We are committed to making financial products more inclusive by creating a modern investment portfolio.